Get the Stockscreener App
6.66
0.76%
0.05
After Hours:
6.36
-0.30
-4.50%
Generation Bio Co stock is traded at $6.66, with a volume of 761.69K.
It is up +0.76% in the last 24 hours and up +51.36% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$6.61
Open:
$6.45
24h Volume:
761.69K
Relative Volume:
2.40
Market Cap:
$44.86M
Revenue:
-
Net Income/Loss:
$-126.61M
P/E Ratio:
-3.398
EPS:
-1.96
Net Cash Flow:
$-60.14M
1W Performance:
+60.48%
1M Performance:
+51.36%
6M Performance:
-2.06%
1Y Performance:
-71.42%
1-Day Range:
$5.75
$6.68
1-Week Range:
$3.96
$6.95
52-Week Range:
$3.004
$29.40
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
6.66 | 44.52M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
Can Generation Bio Co. Bounce Back From Weekly LowBreakout Watch & Real-Time Volume Analysis - newsyoung.net
Fate Therapeutics, Generation Bio, and ORIC Pharmaceuticals Announce Workforce Reductions Amid Restructuring Efforts - geneonline.com
Should you hold or exit Generation Bio Co. nowTrade Risk Summary & Real-Time Chart Pattern Alerts - Newser
JMP Securities reiterates Market Perform rating on Generation Bio stock By Investing.com - Investing.com Nigeria
How to escape a deep drawdown in Generation Bio Co.Portfolio Update Report & Daily Profit Focused Stock Screening - Newser
Generation Bio Co. Warns Stakeholders of Persistent Business Risks in 2024 Report - TipRanks
Why Generation Bio Co. stock attracts strong analyst attentionTrade Risk Assessment & AI Powered Market Entry Ideas - Newser
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates - MSN
What institutional flow reveals about Generation Bio Co.Wall Street Watch & Daily Oversold Bounce Ideas - Newser
Generation Bio Co. recovery potential after sell offOptions Play & Precise Trade Entry Recommendations - Newser
Generation Bio Co (GBIO Stock: A Sea of Opportunity - investchronicle.com
Generation Bio Shares Surge Following Restructuring Plans, Q2 Results - MarketScreener
Generation Bio soars as it explores strategic alternatives - Seeking Alpha
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves - NewsBreak: Local News & Alerts
Generation Bio Co. stock prediction for this weekJuly 2025 Update & Low Drawdown Trading Techniques - Newser
Wedbush downgrades Generation Bio stock rating to Neutral amid restructuring - Investing.com Canada
Generation Bio Stock Surged 31% Pre-Market Today – What’s Going On? - Stocktwits
Wedbush Downgrades Generation Bio to Neutral From Outperform, Price Target is $7 - MarketScreener
Jefferies lowers Generation Bio stock price target to $12 from $40 - Investing.com Nigeria
Generation Bio shares rise 28.64% premarket after announcing new data for its novel ctLNP and evaluating strategic alternatives. - AInvest
Visual trend scoring systems applied to Generation Bio Co.July 2025 Reactions & Free High Accuracy Swing Entry Alerts - Newser
Generation Bio Co. Reports Promising Data and Financial Results - TipRanks
Published on: 2025-08-13 00:40:37 - Newser
Visual analytics tools that track Generation Bio Co. performancePortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Generation Bio Reports Q2 Revenue Drop of 81%, Announces 90% Workforce Reduction and Strategic Review - AInvest
What recovery options are there for Generation Bio Co.Market Risk Report & Daily Stock Momentum Reports - Newser
Generation Bio shares rise 38.27% after-hours after announcing new data for its novel ctLNP. - AInvest
Will Generation Bio Co. bounce back from current supportIntraday Price Action Forecast Planner - Newser
Generation Bio Co reports results for the quarter ended June 30Earnings Summary - TradingView
Generation Bio to cut 90% of workforce amid strategic review - Investing.com
Generation Bio's T Cell Delivery Success Leads to Strategic Review as Company Cuts 90% of Workforce - Stock Titan
Using AI based signals to follow Generation Bio Co.Free Trend Analysis for Safer Trades - Newser
Using fundamentals and technicals on Generation Bio Co.Weekly Outlook for Short Term Investors - Newser
Institutional scanner results for Generation Bio Co.Smart Money Strategy for Growth Stocks - Newser
Published on: 2025-08-11 23:12:12 - Newser
Published on: 2025-08-11 21:13:44 - Newser
Long term hold vs stop loss in Generation Bio Co.Free Step-by-Step Stock Investment Guide - Newser
Measuring Generation Bio Co.’s beta against major indicesRisk Balanced Picks for Safer Trading - Newser
How to interpret RSI for Generation Bio Co. stockWeekly Market Direction and Sector Summary - Newser
Forecasting Generation Bio Co. price range with options dataDaily Technical Chart Pattern Analysis Report - Newser
Can Generation Bio Co. Rally Enough to Break EvenDay Trading Signals With High Precision Reviewed - beatles.ru
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):